Provided by Tiger Trade Technology Pte. Ltd.

BioNTech SE

116.57
+5.685.12%
Post-market: 117.000.4300+0.37%19:59 EDT
Volume:2.96M
Turnover:345.25M
Market Cap:29.28B
PE:-15.00
High:120.33
Open:110.92
Low:110.89
Close:110.89
52wk High:124.00
52wk Low:79.52
Shares:251.20M
Float Shares:108.00M
Volume Ratio:1.03
T/O Rate:2.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.7726
EPS(LYR):-5.5184
ROE:-9.30%
ROA:-5.41%
PB:1.41
PE(LYR):-21.12

Loading ...

CANCOM SE (0O0F) Gets a Hold from Berenberg Bank

TIPRANKS
·
May 01

Deutsche Boerse (0H3T) Receives a Buy from Warburg Research

TIPRANKS
·
Apr 28

Earning Preview: BioNTech SE this quarter’s revenue is expected to decrease by 5.87%, and institutional views are predominantly bullish

Earnings Agent
·
Apr 28

European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading

MT Newswires Live
·
Apr 27

BioNTech Price Target Maintained With a $130.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 27

BioNTech, HPE, BitMine, US Bancorp, Rezolve AI Shock

TIPRANKS
·
Apr 25

Top BioNTech Executive Cashes In With Major Stock Sale Shock

TIPRANKS
·
Apr 24

BioNTech COO Sierk Poetting disposes of $5.53 million in common shares

Reuters
·
Apr 24

Inventiva names Axel-Sven Malkomes CFO in leadership reshuffle

Reuters
·
Apr 23

US CDC will not publish report showing COVID vaccine effectiveness

Reuters
·
Apr 22

Timken Announces Leadership Transition in Engineered Bearings Segment

TIPRANKS
·
Apr 22

BioNTech SE ADR Rises 6.1%, Outperforms Market

Dow Jones
·
Apr 22

Stock Track | BioNTech Soars 5.31% Intraday on Announcement of Upcoming Q1 2026 Results

Stock Track
·
Apr 21

BioNTech to report first-quarter results, host investor call and webcast

Reuters
·
Apr 21

Sagimet Biosciences Appoints Andreas Grauer as Chief Medical Officer

TIPRANKS
·
Apr 21

Indonesian Health Minister: Measles Spreads Faster Than COVID-19

Tempo
·
Apr 20

Assessing BioNTech (NasdaqGS:BNTX) Valuation After Recent Share Price Momentum

Simply Wall St.
·
Apr 20

Press Release: Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer

Dow Jones
·
Apr 20

Sanofi Says Its COVID-19 Vaccine Shows Better Tolerability Than Moderna Alternative in Phase 4 Trial

MT Newswires Live
·
Apr 20

Sanofi says COVID-19 vaccine showed better tolerability than Moderna’s

TIPRANKS
·
Apr 18